TSS
LUCD icon

Two Sigma Securities’s Lucid Diagnostics LUCD Stock Holding History

Two Sigma Securities’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.7K Buy
+39,921
New +$43K ﹤0.01% 1401
2026
Q1 		– Sell
-11,601
Closed -$12.6K – 1960
2025
Q4 		$12.6K Buy
+11,601
New +$13K ﹤0.01% 1259
2025
Q1 		– Sell
-19,316
Closed -$15.8K – 1888
2024
Q4 		$15.8K Buy
+19,316
New +$17K ﹤0.01% 1357
2024
Q3 		– Sell
-27,753
Closed -$22.8K – 3319
2024
Q2 		$22.8K Buy
+27,753
New +$23.5K ﹤0.01% 2676

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Two Sigma Securities's LUCD Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Lucid Diagnostics (LUCD) in Q2 2026: 39,921 shares worth $42.7K. The stake represents ﹤0.01% of the portfolio and ranks #1401 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in LUCD as recently as Q4 2025.

Two Sigma Securities first reported a position in LUCD in Q2 2024 and has held it in 4 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Two Sigma Securities held 39,921 shares of Lucid Diagnostics worth $42.7K as of Q2 2026.
  • Lucid Diagnostics was a new Two Sigma Securities position in Q2 2026.
  • Lucid Diagnostics made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1401 holding.
  • Two Sigma Securities first reported a position in Lucid Diagnostics in Q2 2024 and has held it in 4 quarters since.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.